Firmenich intends to enhance its ability to create healthy and delicious food and drink products for its customers.
The acquisition was executed by Firmenich’s wholly-owned subsidiary Sentry Merger Sub, which purchased all outstanding shares of common Senomyx stock at a price of $1.50 per share in an all cash transaction.
In September, Firmenich entered into a definitive agreement to acquire Senomyx.
At the time of the deal, Firmenich CEO Gilbert Ghostine said: “Building on our world-class science and pioneering taste platform, this strategic acquisition confirms our commitment to being the partner of choice in taste and nutrition.
Senomyx will become a wholly-owned subsidiary of Firmenich and its common stock will cease trading on the NASDAQ Global Select Market.
Senomyx will be integrated into Firmenich’s North America research and development (R&D) organisation, and its products will be commercialised through its Taste Platform.
The company’s R&D operations will remain in San Diego and continue to focus on discovering and developing flavours and sweetener solutions.
Senomyx sells its Complimyx brand flavour ingredients Sweetmyx, Savorymyx and Bittermyx under its direct sales programme to companies for use in various foods and beverages.
